Creative Newtech Preferential Issue
Creative Newtech seeks approval to issue up to 2.25 lakh shares to acquire 82.44% of Zicom SaaS. Share-swap consideration is up to Rs 25.50 Crore.
- Value
- ₹25.50 Cr
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
10 announcements with these filters
Creative Newtech seeks approval to issue up to 2.25 lakh shares to acquire 82.44% of Zicom SaaS. Share-swap consideration is up to Rs 25.50 Crore.
Creative Newtech approved 100% acquisition of Zicom SaaS for Rs. 50.50 Crore via share swap and cash. Target becomes wholly-owned subsidiary in electronic security.
Creative Newtech is pivoting from high-volume distribution to higher-margin brand ownership and technology infrastructure, evidenced by EBITDA growing 3x faster than revenue.
Q2 FY27 consolidated income ₹754.80 Cr (+14.43% YoY), EBITDA ₹40.11 Cr (+50.70%), PAT ₹25.94 Cr (+36.88%). Strategy: owned brands, surveillance, data infrastructure.
Creative Newtech reported Q2 FY27 standalone total income of Rs.664.55 Crore, with PAT up 78.43% YoY to Rs.12.65 Crore. The media release also covers consolidated results and recent acquisition and partnership developments.
Creative Newtech Ltd reported revenue from operations of ₹752.1 Cr (+14.8% YoY) and net profit of ₹25.9 Cr (+37.0% YoY) for Q2 FY27.
Creative Newtech's subsidiary won the 'New Rising Star' award for WOZOYO at Amazon Ads Summit 2026. The recognition highlights the brand's growing digital marketplace presence.
Creative Newtech will hold a board meeting on 28-Oct-2026 to consider unaudited quarterly results for September 2026. Trading window remains closed until 01-Nov-2026.
Creative Newtech Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required by SEBI regulations.
Creative Newtech Limited held its 22nd Annual General Meeting on September 30, 2026. The proceedings covered financial results, dividend declaration, director appointments, and ESOP approvals.